Lexicon Pharma (LXRX)
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the trea...
- Open
- 2.250
- High
- 2.255
- Low
- 2.215
- Prev. Close
- 2.260
- Volume
- 1.04M
- Turnover
- 2.33M
- Avg Price
- 2.234
- Bid/Ask Ratio
- --
- Amplitude
- 1.77%
- 52wk High
- 2.680
- Volume Ratio
- 0.39
- Turnover Ratio
- 0.48%
Lexicon Pharma Analyst Rating
View moreForecast & Rating
Aug 24, 2026Price forecast
$3.8672.14%
Forecast & RatingBuy
5analysts
- Strong buy40.00%
- Buy20.00%
- Hold40.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Sep 1 at 08:09 PM
Lexicon to present at Citi Biopharma Back to School investor conference
- Unusual Whales · Sep 1 at 08:06 PM
Lexicon Pharmaceuticals to Participate at Three Upcoming Investor Conferences
- Simplywall · Sep 1 at 04:35 PM
Why Lexicon Pharmaceuticals (LXRX) Is Back In The Spotlight
- PUBT · Aug 31 at 12:32 PM
Lexicon post hoc SOLOIST-WHF analysis shows sotagliflozin benefit holds across baseline blood pressure levels
- Global Report · Aug 25 at 10:12 AM
Niche Equities Show Divergent Q2 2026 Results Amid Market Shifts
- prnewswire · Aug 17 at 02:33 PM
10:32 ETHypertrophic Cardiomyopathy Market Set for Transformation Over the Next Decade with the Emergence of Targeted Cardiac Therapies Beyond Conventional Beta-blockers, Calcium Channel Blockers, and Antiarrhythmic Agents | DelveInsight
